Delivery Order SPE2DB22D1202-SPE2DB25FUPM6

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,205.52 firm-fixed-price delivery order contract is for the supply of SUNOSI 75 MG Tablets. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $4,156.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is a delivery order for the supply of SUNOSI 75 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of November 20, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SUNOSI 75 MG TABLET 30S. The award, valued at $1,299.54, is a firm fixed-price contract with a completion date of July 26, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,282.92 Firm Fixed Price Delivery Order covers the supply of SUNOSI 150 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The award, valued at $1,414.28, is for the delivery of 4565711491 - SUNOSI 75 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of September 9, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded numerous...
This federal contract award, valued at $1,282.62, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Corporate Office of Amerisourcebergen Drug Corp. The contract is for the delivery of 4564883884 - SUNOSI 75 MG TABLET 30S, a pharmaceutical product, to be completed by June 12, 2024. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major pharmaceutical distributor that has extensive experience in fulfilling...
This federal contract award with ID SPE2DB24D1201|SPE2DB25FJBFW was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.11 firm fixed-price delivery order covers the supply of SUNOSI 150 MG TABLET 30S, with a period of performance through January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,369.99 firm fixed price contract is for the supply of Sunosi 75 mg tablets to support military healthcare programs. The contract has a period of performance through January 31, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,025.08, is a Firm Fixed Price Delivery Order for the supply of SUNOSI 150 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,600.17 for the supply of Sunosi 150 mg tablets. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUPM6
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,792.60, is for the delivery of SUNOSI 75 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 15, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award has no set-aside designation, indicating open competition.

Generated 4/16/25, 5:54 PM